Variant report
Variant | esv3475303 |
---|---|
Chromosome Location | chr7:70419016-70427914 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs529767015 | chr7:70419055-70419056 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs1568864 | chr7:70419110-70419111 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs552148998 | chr7:70419168-70419169 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs386714473 | chr7:70419196-70419197 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs181030449 | chr7:70419197-70419198 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs372182918 | chr7:70419213-70419214 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs151121102 | chr7:70419296-70419297 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs183765514 | chr7:70419339-70419340 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs536362031 | chr7:70419360-70419361 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs375436840 | chr7:70419405-70419406 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs549806012 | chr7:70419455-70419456 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs554328473 | chr7:70419466-70419467 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs575992541 | chr7:70419500-70419501 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs536687008 | chr7:70419539-70419540 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs1464854 | chr7:70419540-70419541 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs577238613 | chr7:70419571-70419572 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs188783464 | chr7:70419627-70419628 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs139946492 | chr7:70419628-70419629 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs563274931 | chr7:70419633-70419634 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs574504495 | chr7:70419667-70419668 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs542310389 | chr7:70419673-70419674 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs367760809 | chr7:70419678-70419679 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs531027410 | chr7:70419714-70419715 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs181243798 | chr7:70419717-70419718 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs12672700 | chr7:70419737-70419738 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs186220425 | chr7:70419760-70419761 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs12666737 | chr7:70419764-70419765 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs546855788 | chr7:70419811-70419812 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs1464853 | chr7:70419818-70419819 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
30 | rs535629158 | chr7:70419840-70419841 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs551152816 | chr7:70419884-70419885 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs548516866 | chr7:70419906-70419907 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs7797232 | chr7:70419914-70419915 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs537154113 | chr7:70419945-70419946 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs28716291 | chr7:70419987-70419988 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs1464852 | chr7:70419994-70419995 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs1464851 | chr7:70420012-70420013 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs145811004 | chr7:70420018-70420019 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs112460392 | chr7:70420044-70420045 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs574670167 | chr7:70420076-70420077 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs373836200 | chr7:70420091-70420092 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs546178629 | chr7:70420116-70420117 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs141688267 | chr7:70420139-70420140 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs145432291 | chr7:70420152-70420153 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs10227112 | chr7:70420221-70420222 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs528428781 | chr7:70420231-70420232 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs539433903 | chr7:70420243-70420244 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs540528232 | chr7:70420267-70420268 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs370235650 | chr7:70420283-70420284 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs562292729 | chr7:70420300-70420301 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Biliary cancer | 19435499 | CNVD |
Williams-beuren syndrome | 22470819 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Cancer | 21183584 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Gastric cancer | 24379144 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Lissencephaly | 21572526 | CNVD |
Breast cancer | 17603634 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Astrocytoma | 22246337 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 16461572 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Multiple myeloma | 17550852 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Bladder cancer | 21909424 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164920 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung cancer | 21911935 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Chordoma | 18071362 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Dyslexia | 22102821 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:70416800-70419600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr7:70417400-70419200 | Enhancers | Fetal Intestine Large | intestine |
3 | chr7:70418200-70419800 | Enhancers | Fetal Stomach | stomach |
4 | chr7:70418600-70419800 | Enhancers | Fetal Muscle Leg | muscle |
5 | chr7:70418800-70419200 | Enhancers | Fetal Intestine Small | intestine |
6 | chr7:70418800-70419200 | Weak transcription | Fetal Kidney | kidney |
7 | chr7:70419200-70419400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
8 | chr7:70419200-70419800 | Enhancers | Fetal Kidney | kidney |
9 | chr7:70419800-70421000 | Weak transcription | Fetal Muscle Leg | muscle |
10 | chr7:70421000-70421600 | Enhancers | Fetal Muscle Leg | muscle |
11 | chr7:70421600-70423000 | Weak transcription | Fetal Muscle Leg | muscle |
12 | chr7:70423000-70423200 | Enhancers | Fetal Muscle Leg | muscle |